Surmodics PE Ratio 2010-2023 | SRDX
Current and historical p/e ratio for Surmodics (SRDX) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Surmodics PE ratio as of April 22, 2024 is 39.06.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Surmodics PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-23 | 26.92 | 70.84 | |
2023-12-31 | 36.35 | $0.38 | 95.66 |
2023-09-30 | 32.09 | $-0.12 | 0.00 |
2023-06-30 | 31.31 | $-1.65 | 0.00 |
2023-03-31 | 22.78 | $-2.58 | 0.00 |
2022-12-31 | 34.12 | $-2.32 | 0.00 |
2022-09-30 | 30.40 | $-1.96 | 0.00 |
2022-06-30 | 37.23 | $-0.92 | 0.00 |
2022-03-31 | 45.33 | $-0.75 | 0.00 |
2021-12-31 | 48.15 | $0.12 | 401.25 |
2021-09-30 | 55.60 | $0.30 | 185.33 |
2021-06-30 | 54.25 | $0.10 | 542.50 |
2021-03-31 | 56.07 | $0.52 | 107.83 |
2020-12-31 | 43.52 | $0.05 | 870.40 |
2020-09-30 | 38.91 | $0.08 | 486.38 |
2020-06-30 | 43.24 | $0.56 | 77.21 |
2020-03-31 | 33.32 | $0.49 | 68.00 |
2019-12-31 | 41.43 | $0.47 | 88.15 |
2019-09-30 | 45.74 | $0.55 | 83.16 |
2019-06-30 | 43.17 | $0.16 | 269.81 |
2019-03-31 | 43.48 | $-0.15 | 0.00 |
2018-12-31 | 47.26 | $-0.13 | 0.00 |
2018-09-30 | 74.65 | $-0.34 | 0.00 |
2018-06-30 | 55.20 | $-0.18 | 0.00 |
2018-03-31 | 38.05 | $0.07 | 543.57 |
2017-12-31 | 28.00 | 0 | 0.00 |
2017-09-30 | 31.00 | $0.29 | 106.90 |
2017-06-30 | 28.15 | $0.46 | 61.20 |
2017-03-31 | 24.05 | $0.71 | 33.87 |
2016-12-31 | 25.40 | $0.73 | 34.79 |
2016-09-30 | 30.09 | $0.75 | 40.12 |
2016-06-30 | 23.48 | $0.77 | 30.49 |
2016-03-31 | 18.41 | $0.77 | 23.91 |
2015-12-31 | 20.27 | $0.94 | 21.56 |
2015-09-30 | 21.84 | $1.02 | 21.41 |
2015-06-30 | 23.42 | $0.97 | 24.14 |
2015-03-31 | 26.03 | $0.93 | 27.99 |
2014-12-31 | 22.10 | $0.88 | 25.11 |
2014-09-30 | 18.16 | $0.87 | 20.87 |
2014-06-30 | 21.42 | $0.96 | 22.31 |
2014-03-31 | 22.60 | $0.91 | 24.84 |
2013-12-31 | 24.39 | $1.01 | 24.15 |
2013-09-30 | 23.78 | $1.04 | 22.87 |
2013-06-30 | 20.01 | $0.94 | 21.29 |
2013-03-31 | 27.25 | $0.90 | 30.28 |
2012-12-31 | 22.36 | $0.72 | 31.06 |
2012-09-30 | 20.22 | $0.58 | 34.86 |
2012-06-30 | 17.30 | $-0.32 | 0.00 |
2012-03-31 | 15.37 | $-0.27 | 0.00 |
2011-12-31 | 14.66 | $-0.23 | 0.00 |
2011-09-30 | 9.10 | $-0.40 | 0.00 |
2011-06-30 | 11.10 | $-0.91 | 0.00 |
2011-03-31 | 12.50 | $-1.18 | 0.00 |
2010-12-31 | 11.87 | $-1.34 | 0.00 |
2010-09-30 | 11.92 | $-1.21 | 0.00 |
2010-06-30 | 16.41 | $0.20 | 82.05 |
2010-03-31 | 20.94 | $0.45 | 46.53 |
2009-12-31 | 22.66 | $0.71 | 31.92 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.361B | $0.133B |
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
Stryker (SYK) | United States | $124.672B | 30.91 |
Medtronic (MDT) | Ireland | $106.983B | 15.15 |
Boston Scientific (BSX) | United States | $99.792B | 33.18 |
EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
ResMed (RMD) | United States | $26.527B | 26.52 |
Terumo (TRUMY) | Japan | $25.252B | 35.66 |
Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
Baxter (BAX) | United States | $20.516B | 14.96 |
Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
Insulet (PODD) | United States | $11.513B | 60.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
Demant (WILYY) | Denmark | $9.853B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.989B | 23.80 |
BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
Haemonetics (HAE) | United States | $4.247B | 21.72 |
Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
Envista Holdings (NVST) | United States | $3.456B | 13.14 |
QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
Neogen (NEOG) | United States | $2.552B | 24.54 |
Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
ICU Medical (ICUI) | United States | $2.348B | 17.52 |
TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
Owens & Minor (OMI) | United States | $1.856B | 17.82 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
InMode (INMD) | Israel | $1.439B | 7.45 |
LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
Warby Parker (WRBY) | United States | $1.218B | 0.00 |
AtriCure (ATRC) | United States | $1.099B | 0.00 |
MacroGenics (MGNX) | United States | $0.964B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
Quanterix (QTRX) | United States | $0.623B | 0.00 |
Valneva SE (VALN) | France | $0.552B | 0.00 |
Jin Medical (ZJYL) | China | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
PetIQ (PETQ) | United States | $0.486B | 18.14 |
TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
ZimVie (ZIMV) | United States | $0.422B | 25.82 |
Biote (BTMD) | United States | $0.414B | 3.94 |
OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
Zynex (ZYXI) | United States | $0.358B | 41.26 |
Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
Cerus (CERS) | United States | $0.306B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.178B | 0.00 |
High Tide (HITI) | Canada | $0.171B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.103B | 8.80 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Safety Shot (SHOT) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.52 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |